Agronomics Stock Price, News & Analysis

Agronomics (LSE:ANIC) announced that its portfolio company, Clean Food Group (CFG), has acquired the assets of Algal Omega 3 Ltd, gaining access to 1 million liters of fermentation capacity in Liverpool. The acquisition positions CFG as one of the world's largest manufacturers of yeast fermentation-derived sustainable oils and fats.

The 12-acre Liverpool facility includes R&D capabilities and has already demonstrated successful commercial-scale production with 2 tons of oil in a recent fermentation run. CFG recently received regulatory approval for its CLEAN Oil™ 25 product for cosmetic use in the UK, Europe, and US. The company aims to address a $20 billion market opportunity and plans a Series A funding round in H1 2026.

Agronomics' investment of £1.6 million in CFG is currently valued at £6.9 million, representing approximately 4.8% of Agronomics' last stated Net Asset Value as of June 30, 2025.

Onego Bio, a portfolio company of Agronomics (AGNMF), has achieved a significant regulatory milestone as the FDA issued a "no questions" letter regarding the GRAS status of its Bioalbumen® product. This egg protein alternative, produced through precision fermentation, can now be used as a dietary protein source and functional ingredient in various food applications.

The company plans to construct its flagship production facility in Jefferson County, Wisconsin, to scale manufacturing. Agronomics has invested £7.1 million in Onego Bio, with the position currently valued at £11.2 million, representing approximately 7.5% of Agronomics' Net Asset Value as of June 30, 2025.

Clean Food Group (CFG), a portfolio company of Agronomics (AGNMF), has achieved a significant milestone by receiving regulatory approval for its CLEAN Oil™ 25 product as a cosmetic ingredient in the UK, Europe, and United States. The precision-fermented oil offers a sustainable alternative to palm oil, which is currently used in 70% of cosmetic products.

Developed in collaboration with THG LABS and Croda International plc, this breakthrough targets the global personal care and cosmetics sector, projected to reach $776.35 billion by 2030. Agronomics' investment of £1.6 million in CFG is currently valued at £6.9 million, representing approximately 4.8% of Agronomics' last stated Net Asset Value as of June 2025.

Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of June 30, 2025, at 14.40 pence per share, representing a 2.8% decrease from March 2025. The company's total Net Assets stood at £145.3 million, including £141.8 million in investments and £3.6 million in cash.

The quarter saw a £4.1 million decline in NAV, primarily due to unrealized FX losses of £4.2 million from currency fluctuations. Despite this, portfolio companies achieved significant milestones, including BlueNalu's expanded partnership with Nomad Foods, Liberation Bioindustries's strategic partnership with NEOM, and Meatable's collaboration with TruMeat for cultivated meat commercialization.

Agronomics (AGNMF) has announced the release of their Q2 2025 newsletter, which is available through a provided MailChimp link. The press release, issued from Douglas, Isle of Man, contains minimal information as it only directs readers to access the newsletter through an external link. Without access to the actual newsletter content, specific details about the company's quarterly performance, updates, or developments cannot be determined.

Meatly, a portfolio company of Agronomics (AGNMF), has achieved significant breakthroughs in cultivated meat production technology. The company has developed an in-house 320-liter bioreactor at £12,500, representing a 95% cost reduction compared to traditional £250,000 biopharma reactors. Additionally, Meatly has reduced its protein-free medium costs to £0.22/L, with potential costs of £0.015/L at industrial scale. The medium supports cell growth for over 175 doublings, surpassing historical performance. Following regulatory approval in July 2024, Meatly launched 'Chick Bites', the world's first cultivated pet food, at Pets at Home in London. Having raised £7M to date, the company is now pursuing a Series A funding round to finance a new industrial facility with multiple 20,000L scale bioreactors.

Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of March 31, 2025, at 14.81 pence per share, representing a 0.80% decrease from December 2024. The company's Net Assets stand at £149 million, including £146 million in investments and £4 million in cash. The current share price of 7.15 pence represents a 52% discount to NAV.

Key portfolio developments include: Liberation Labs securing a $50.5M convertible note raise, Formo Bio obtaining a €35M EIB loan, and Solar Foods receiving €10M in government funding. Notable milestone: Good Dog Food (Meatly) became the first company to sell cultivated meat for pet food in Europe. The quarter saw a £1.2M NAV decline, mainly due to FX losses of £2.5M, partially offset by a £1.3M value increase in Solar Foods holding.

Agronomics (LSE:ANIC) announced that its portfolio company Liberation Labs has formed a manufacturing partnership with Dutch startup Vivici. Liberation Labs will produce Vivici's flagship ingredient, Vivitein™ BLG, a dairy protein made through precision fermentation, at its Richmond, Indiana facility starting in 2026. The facility, currently in late-stage construction, features a 600,000-liter capacity with dedicated downstream processing. Agronomics has invested US$27 million in Liberation Labs, with the position currently valued at £34.1 million, representing ~23% of Agronomics' Net Asset Value as of December 2024. The partnership aims to address growing protein demand in the US market, enabling the production of innovative products like clear protein drinks, protein powders, and vegan-friendly protein bars.

Agronomics (LSE:ANIC) announces a strategic collaboration between its portfolio company Meatable and TruMeat to advance cultivated meat commercialization. Meatable, a cultivated meat technology leader, will partner with TruMeat, a contract manufacturer, to build a state-of-the-art facility in Singapore using Meatable's technology.

The collaboration aims to optimize processes and media development to produce cultivated meat at competitive price points and commercial scale. Agronomics has invested €9.2 million in Meatable, currently valued at £11.4 million, representing approximately 7.5% of Agronomics' last stated Net Asset Value as of December 31, 2024.

The new facility will be Singapore's first to deliver cultivated meat at cost levels and volumes needed for commercial partners to formulate, test, and launch products in the market.